Milestones achieved in collaboration with Sanofi

We’re excited to announce that we achieved several milestones as part of our collaboration and licensing agreement with Sanofi, including de novo high-resolution cryoEM structures of a Salipro®-embedded G Protein-Coupled Receptor (GPCR) in complex with biologics, as well as in vitro binding assays for interaction affinity determination, triggering milestone payments. 

Congratulations to both teams for these achievements!

Previous
Previous

Salipro to attend NLSDays 2023 in Copenhagen

Next
Next

Salipro Biotech to join PSDI 2023